drugset / Trial / NCT00233935

Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus

NCT00233935

Phase 1 Completed 55 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupTriple-blindPrevention

Summary

The goal of this clinical research study is to test the safety of defined green tea catechin extract at different dose levels. Researchers also want to find out what effects, good and bad, it may have on individual and their risk for esophagus cancer. Esophagus cancer is an increased risk associated with Barrett's esophagus. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of defined green tea catechin extract may prevent esophageal cancer.

Timeline

Start
2005-11
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Sinecatechins Unknown 200 mg Oral
Subject Sinecatechins Unknown 400 mg Oral
Subject Sinecatechins Unknown 600 mg Oral

Indications